• Cytokine signaling: from jakinibs to the epigenome (Ray A. and Robert L. Kroc Lectureship in Rheumatology) 

  O'Shea, John J., Jr. (2021-02-12)

• Health and digital technology partnerships: too close for comfort? 

  Sullivan, Laura Specker (2021-02-09)

  Digital technology companies are seeking out partnerships with medical institutions at an astounding rate. Those involved tout these partnerships as empowering consumers, driving innovation, and increasing efficiency. At ...

• (Glucose) metabolism a common soil linking diabetes mellitus, heart failure and cancer? 

  Abel, E. Dale (2021-02-05)

• Updates in lupus: the top 5 news stories every internist should know 

  Dao, Kathryn (2021-01-29)

• High value health care: the role of palliative care 

  Kutner, Jean (2021-01-22)

• The ATS/IDSA guidelines for community-acquired pneumonia in adults: updates and COVID-19 

  Metlay, Joshua (2021-01-15)

• Public health in disasters: "the invisible first responders" 

  Shah, Umair A. (2021-01-12)

  Public health departments have a fundamental ethical responsibility for protecting their communities and over time have acquired important skills in responding to emerging threats. State and local health departments across ...

• Proton pump inhibitors: have we gone too far? 

  Dunbar, Kerry (2021-01-08)

• Genetic syndromes of intestinal polyposis and cancer predisposition 

  Engelking, Luke (2020-12-11)

• Tolerance & integrity: defining boundaries of acceptable treatment & non-treatment decisions 

  Feudtner, Chris (2020-12-08)

  Clinical ethics consultations often involve some degree of conflict between patients (or their parents) and clinical teams regarding pursuing--or not pursuing--a specific treatment, or regarding some other request or ...

• COVID-19 in long term care facilities 

  Gangavati, Anupama (2020-12-04)

• New concepts in pathogenesis and treatment of alcohol-associated liver disease 

  Mitchell, Mack C. (2020-11-20)

• Good sport and good doctoring: when patients want enhancements, not therapy (The Daniel W. Foster, M.D., Visiting Lectureship in Medical Ethics) 

  Murray, Thomas H. (2020-11-10)

  We know that athletes, from aspiring teens to professional and aging masters, use drugs to enhance their performance. We know that in almost all sports using performance-enhancing drugs (PEDs) is forbidden. Why do athletes ...

• Menopause mangement: a generalist's perspective on hormone therapy 

  Bonnema, Rachel (2020-11-06)

• Updates on the treatment of COVID-19 

  Cutrell, James (2020-10-30)

• Families in the ICU 

  DeLisle, Sylvain (2020-10-16)

• The "difficult patient" reconceived: an expanded moral mandate for clinical ethics 

  Fiester, Autumn M. (2020-10-13)

  Between 15%-60% of patients are considered "difficult" by their treating physicians. Patient psychiatric pathology is the conventional explanation for why patients are deemed "difficult." But the prevalence of the problem ...

• Mutations in G proteins and G protein-coupled receptors in human disease: implications for diagnosis and treatment 

  Spiegel, Allen M. (2020-10-09)

• Late cardiopulmonary sequelae of premature birth: why the internist needs a birth history 

  Goss, Kara (2020-10-02)

• Decentralizing outpatient diabetes care: a collaborative approach 

  Gunasekaran, Uma (2020-09-18)

View more